Kyle Daniel Nefzger, APRN, FNP-C

Kyle Nefzger practices at Urgent Care Now in Carmichael, California.

Kyle Nefzger's NPI, 1134873656, was assigned on February 4, 2022. Kyle Nefzger holds California license 95019395.

Kyle Nefzger's primary practice is Urgent Care Now, at 6651 Madison Ave, Carmichael, CA 95608-0602. The practice phone is (916) 727-1400.

Kyle Nefzger's primary practice is Urgent Care Now in Carmichael, California. The medical group on file is Urgent Care Now. Dmand AI also links Kyle Nefzger to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kyle Nefzger practices. Vendor and product names are available with a free account.

Family is Kyle Nefzger's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Kyle Nefzger is licensed in California.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, ankle or foot injury, broken or dislocated ankle/ or foot, carpal tunnel syndrome, conjunctivitis and ear infection among the conditions Kyle Nefzger treats.

CMS data shows 497 Medicare services from Kyle Nefzger across 11 procedure codes in 2024, for 263 Medicare patients. Medicare paid $20,946 for them. Every service was in an office.

CMS counts 263 Medicare patients who saw Kyle Nefzger in 2024. The largest group is 65 to 74, with 112 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kyle Nefzger's median patient age at 37, with 60% women.

In 2024, Kyle Nefzger wrote 379 Medicare Part D claims for 313 patients. 93% of them were for generic drugs. CMS names the drug for 253 of them, across 9 drugs with 11 or more claims each, at $2,175 in total drug cost.

CMS lists Kyle Nefzger as offering telehealth.

CMS Open Payments shows 1 general payment to Kyle Nefzger from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $16.